Company: JWEL
Filing Date: 2025-08-26
Form Type: F-3
Source: 0001213900-25-080759
Chunk: 30

Company: Jowell Global Ltd.
Filing Date: 2025-08-26
Form: F-3
Chunk 30
---
 of these forward-looking statements, whether as a result of new information, future events or otherwise. If we do update
or correct one or more forward-looking statements, you should not conclude that we will make additional updates or corrections with respect
thereto or with respect to other forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual
results and events to differ materially from our forward-looking statements is included in our periodic reports filed with the SEC and
in the “Risk Factors” section of this prospectus.

<div align='center'>USE OF PROCEEDS</div>

Except as described in any
prospectus supplement and any free writing prospectus in connection with a specific offering, we currently intend to use the net proceeds
from the sale of the securities offered under this prospectus to fund the development and the growth of our business, primarily working
capital, and for general corporate purposes. We may also use a portion of the net proceeds to acquire or invest in technologies and/or
businesses that we believe will enhance the value of our Company, although we have no current commitments or agreements with respect to
any such transactions as of the date of this prospectus. We have not determined the amount of net proceeds to be used specifically for
the foregoing purposes. As a result, our management will have broad discretion in the allocation of the net proceeds and investors will
be relying on the judgment of our management regarding the application of the proceeds of any sale of the securities.

<div align='center'>DESCRIPTION OF SHARE CAPITAL</div>

The following is a summary
of our share capital and certain provisions of our Second Amended and Restated Memorandum and Articles of Association. This summary does
not purport to be complete and is qualified in its entirety by the provisions of our Second Amended and Restated Memorandum and Articles
of Association and applicable provisions of the laws of the Cayman Islands. You are encouraged to read the relevant provisions of the
Companies Act and of our Second Amended and Restated Memorandum and Articles of Association as they relate to the following summary.

See “Where You Can Find
More Information” elsewhere in this prospectus for information on where you can obtain copies of our Second Amended and Restated
Memorandum and Articles of Association, which have been filed with and are publicly available from the SEC.

Our authorized share capital
is $800,000 divided into shares of which (i) 450,000,000 shares are designated as ordinary shares with a nominal or par value